Researchers at Khalifa University have developed an AI system capable of predicting cardiovascular disease (CVD) risks up to 12 years in advance. The AI model uses data from the Framingham Heart Study to assess long-term CVD risk factors. It outperforms existing methods in predicting CVD incidence over extended periods. Why it matters: This advancement could significantly improve preventative healthcare strategies in the UAE and globally by enabling earlier interventions for individuals at high risk of heart disease.
Researchers from KAUST, King Faisal Specialist Hospital, and collaborators have developed a new method to predict cardiometabolic disease risk in underrepresented ethnic populations using genetic information and public databases. The study focused on Arab communities and created a framework to determine polygenic scores for more accurate heart disease prediction. The framework was validated using records of over 5,000 Arab patients, demonstrating that genetic risk complements conventional risk factors. Why it matters: This research addresses a critical gap in genomic data for non-European populations, potentially leading to more effective and personalized healthcare strategies in the Arab world and beyond.
MBZUAI alumnus Ikboljon Sobirov is using AI to develop new diagnostic tools for cardiovascular disease at the University of Oxford. His research focuses on building imaging biomarkers by integrating transcriptomic data with medical scans. The goal is to predict how a patient will respond to specific medications using only images. Why it matters: This work showcases the potential of AI and multi-modal data to personalize medicine and improve healthcare outcomes in the region and globally.
KAUST researchers have identified the gene 'CIROZ' as responsible for pediatric heart defects and misplacement of internal organs, working with institutes in Saudi Arabia and worldwide. The research examined samples from 16 patients from 10 families, including four from Saudi Arabia, revealing CIROZ's role in embryonic development symmetry. The findings provide insights into heritable diseases, which are more prevalent in Saudi Arabia. Why it matters: Identifying this gene allows for focused research on preventative strategies and curative therapies for congenital heart defects, particularly relevant in regions with higher rates of such diseases.
Researchers from MBZUAI have developed EchoCoTr, a novel spatiotemporal deep learning method for estimating left ventricular ejection fraction (LVEF) from echocardiograms. EchoCoTr combines CNNs and vision transformers to overcome the limitations of each when applied to medical video data. The method achieves state-of-the-art results on the EchoNet-Dynamic dataset, demonstrating improved accuracy compared to existing approaches, with code available on GitHub.
MBZUAI researchers are developing AI applications for malaria prevention in Indonesia using sensory data fusion and digital twins. Another MBZUAI team is using machine learning and computer vision to detect cardiovascular disease from CT scans in collaboration with the University of Oxford. AI-powered remote patient monitoring is also being explored for proactive interventions and chronic disease management. Why it matters: These projects demonstrate the potential of AI to address healthcare challenges in underserved communities and improve disease prevention and management in the region.
KAUST and the Saudi Food and Drug Authority (SFDA) have partnered to develop a new method using nuclear magnetic resonance (NMR) to detect adulterants in olive oil. The method aims to identify and quantify vegetable oils mixed with olive oil, addressing concerns about the mislabeling of olive oil in the Saudi market. KAUST's comprehensive suite of NMR machines was critical for the project. Why it matters: This collaboration enhances food safety and quality control in Saudi Arabia, a major olive oil importer, and helps to ensure consumers receive authentic, high-quality products.